OPTH

Optimi Health Corp. Common Shares

2.34

USD

-0.05

-2.09%

Nov 06, 15:59 UTC -5

Closed

After-Market

2.31

-0.03

-1.28%

Optimi Health Corp. Common Shares (OPTH) Earnings

OPTH Earnings Reports

Positive Surprise Ratio

OPTH beat 0 of 2 last estimates.

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Optimi Health Corp. Common Shares earnings per share and revenue

On Aug 14, 2026, OPTH reported earnings of -0.56 USD per share (EPS) for Q3 26, missing the estimate of -0.40 USD, resulting in a -37.25% surprise. Revenue reached 140.20 thousand, compared to an expected 224.40 thousand, with a -37.52% difference. The market reacted with a -0.42% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

ZOETIS INC.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.52

Actual

$1.75

Surprise

+14.64%

Amylyx Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.38

Actual

-$0.38

Surprise

+1.04%

Guardian Pharmacy Services, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.30

Actual

$0.33

Surprise

+7.84%

Xeris Biopharma Holdings, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.02

Actual

$0.06

Surprise

+144.90%

Cronos Group Inc. Common Share

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.03

Actual

$0.04

Surprise

+17.65%

Collegium Pharmaceutical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.89

Actual

$1.96

Surprise

+3.17%

Ironwood Pharmaceuticals, Inc. - Class A

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.32

Actual

$0.36

Surprise

+9.16%

ARS Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.32

Actual

-$0.36

Surprise

-11.15%

Profound Medical Corp. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.18

Actual

-$0.21

Surprise

-11.41%

Akebia Therapeutics, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.03

Actual

-$0.04

Surprise

-6.95%

FAQ

What were Optimi Health Corp. Common Shares's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Optimi Health Corp. Common Shares reported EPS of -$0.56, missing estimates by -37.25%, and revenue of $140.20K, -37.52% below expectations.

How did the market react to Optimi Health Corp. Common Shares's Q3 2026 earnings?

The stock price moved down -0.42%, changed from $4.79 before the earnings release to $4.77 the day after.

When is Optimi Health Corp. Common Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Optimi Health Corp. Common Shares's next earnings report?

Based on -- analysts, Optimi Health Corp. Common Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.